Chronic mucus hypersecretion in COPD and death from pulmonary infection;Kronisk ekspektoration og risiko for død ved kronisk obstruktiv lungesygdom

Ugeskrift for Laeger

Volumn 158, Issue 45, 1996, Pages 6456-6460

  Prescott, Eva Irene B ^a   Lange, Peter ^b   Vestbo, Jørgen ^b  

^a The Capital Region

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MORTALITY; MUCUS; PATHOPHYSIOLOGY; PNEUMONIA; RISK FACTOR; SECRETION; SMOKING;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MUCUS; PNEUMONIA; RISK FACTORS; SMOKING;

EID: 3342899493     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Peto R, Tinker CM, Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press, 1976.
2. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128: 491-500.
3. Ebi Kryston KL. Predicting 15 year chronic bronchitis mortality in the Whitehall Study. J Epidemiol Community Health 1989; 43:168-72.
4. Ebi Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41: 251-60.
5. Wiles FJ, Hnizdo E. Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med 1991; 85: 27-35.
6. Speizer FE, Fay ME, Dockery DW, Ferris BGJ. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989; 140: S49-55.
7. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-85.
8. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. Am Rev Respir Dis 1986; 134: 688-93.
9. Vollmer WM, McCamant LE, Johnson LR, Buist AS. Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 1989; 129: 1157-69.
10. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium [editorial]. Thorax 1984; 39: 81-5.
11. Monto AS, Higgins MW, Ross HW. The Tecumseh Study of Respiratory Illness. VIII. Acute infection in chronic respiratory disease and comparison groups. Am Rev Respir Dis 1975; 111: 27-36.
12. Comstock GW, Stone RW, Tonascia JA, Johnson DH. Respiratory survey findings as predictors of disability from respiratory diseases. Am Rev Respir Dis 1981; 124: 367-71.
13. Appleyard M. The Copenhagen City Heart Study. Scand J Soc Med 1989; (Suppl 41): 1-160.
14. Lange P, Groth S, Nyboe J, Appleyard M, Mortensen J, Jensen G et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989; 226: 25-32.
15. Cox DR. Regression models and life tables. J R Statist Soc 1972; B 34: 187-220.
16. 1 in the general population [abstract]. Eur Respir J 1991; 4: 5685.
17. Sherman CB, Xu X, Speizer FE, Ferris BG Jr., Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146: 855-9.
18. 1 decline and COPD morbidity. Am J Respir Crit Care Med 1996; 153: 1530-5.